Amy Ritter, PhD
Advertisement
Scientific Editor, BioPharm International
Articles by Amy Ritter, PhD
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform
2
The BioPharm Brief: FDA Designations for a Bispecific CAR-T, a BLA for Friedreich’s Ataxia, and Phase 2b MASH Data for Efinopegdutide
3
Efinopegdutide Meets Primary Endpoint in Phase 2b MASH Trial
4
FDA Grants RMAT and Fast Track Designations to AbelZeta’s Bispecific CAR-T Prizlon-cel in Large B-Cell Lymphoma
5